Biocompatible metal surfaces
First Claim
Patent Images
1. A medical device having a biocompatible surface, the biocompatible surface having been made by a process comprising the steps of:
- providing a metallic member having a tantalum oxide-containing surface thereof, said metallic member being flexible and being sized and shaped as a stent;
treating the tantalum oxide containing surface with an amino-terminated organosilane having amine reactive sites and covalently linking the organosilane with the flexible metallic member to effect a condensation reaction that covalently links the tantalum oxide and silicon moieties of the organosilane in order to form a flexible organosilane-coated tantalum stent;
applying a biologically active agent compostion to the organosilane-coated tantalum stent and forming a covalent linkage between the organosilane and the biologically active agent to provide a coated flexible tantalum stent; and
the coated flexible tantalum stent thus formed has a coating which withstands cracking upon flexure, and the tantalum stent thus formed is a biocompatible tantalum stent which, when implanted within a living body, prevents substantial thrombus from occurring on its surface while not significantly interfering with endothelialization of said surface.
0 Assignments
0 Petitions
Accused Products
Abstract
Metallic surfaces of medical devices or components of medical devices are provided that have enhanced biocompatibility properties. The surfaces are prepared by a two-step procedure including covalently linking an organosilane having amine reactive sites with the surface of the metallic member, typically through a metal oxide thereof. Thereafter, a biologically active agent is covalently linked to the organosilane coating. The two-step process is particularly advantageous for preparing medical devices in the form of stents which need to be bent and flexed during implantation procedures.
515 Citations
10 Claims
-
1. A medical device having a biocompatible surface, the biocompatible surface having been made by a process comprising the steps of:
-
providing a metallic member having a tantalum oxide-containing surface thereof, said metallic member being flexible and being sized and shaped as a stent; treating the tantalum oxide containing surface with an amino-terminated organosilane having amine reactive sites and covalently linking the organosilane with the flexible metallic member to effect a condensation reaction that covalently links the tantalum oxide and silicon moieties of the organosilane in order to form a flexible organosilane-coated tantalum stent; applying a biologically active agent compostion to the organosilane-coated tantalum stent and forming a covalent linkage between the organosilane and the biologically active agent to provide a coated flexible tantalum stent; and the coated flexible tantalum stent thus formed has a coating which withstands cracking upon flexure, and the tantalum stent thus formed is a biocompatible tantalum stent which, when implanted within a living body, prevents substantial thrombus from occurring on its surface while not significantly interfering with endothelialization of said surface. - View Dependent Claims (2, 3, 4, 5, 6)
-
-
7. A medical device having a biocompatible anti-thrombogenic tantalum surface, comprising:
-
a metallic member for a medical device, the metallic member having a tantalum oxide surface and being flexible and being sized and shaped as a stent, the metallic member having a biologically active surface treatment covalently adhered to the tantalum oxide surface; said biologically active surface treatment including an organosilane component having amine reactive sites, the organosilane component having silicon moieties covalently linked to tantalum oxide moieties of the metallic member, said biologically active surface treatment further including a biologically active agent covalently bound to the organosilane component to define a biocompatible tantalum stent; and said biocompatible tantalum stent has a surface which substantially prevents thrombus formation thereonto while avoiding any significant interference of the development of endothelialization of the biocompatible tantalum stent, and said biocompatible tantalum stent has a coating which is flexible and which withstands cracking upon flexure. - View Dependent Claims (8, 9, 10)
-
Specification